Commentary: Selpercatinib versus multi-kinase inhibitors for advanced medullary thyroid cancer: a network meta-analysis of RET-targeted therapies
AD, MH and MC are employees of Esteve Pharmaceuticals S.A. EB and JM are employees of York Health Economics Consortium (YHEC). YHEC was commissioned to produce an independent review by Esteve Pharmaceuticals S.A.The author(s) declared that financial support was received for this work and/or its publication. This commen...
Arnau Domenech, M Hopmans, Erin Barker et al.
· Frontiers in Endocrinology · 0 citations